No abstract available
Publication types
-
Practice Guideline
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acidosis / therapy
-
Adult
-
Analgesics / adverse effects
-
Angiotensin II / antagonists & inhibitors
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Antihypertensive Agents / therapeutic use
-
Calcium Channel Blockers / therapeutic use
-
Child
-
Cyclosporine / therapeutic use
-
Diabetic Nephropathies / drug therapy
-
Diet, Protein-Restricted
-
Exercise
-
Female
-
Fish Oils / therapeutic use
-
Glomerulonephritis, IGA / therapy
-
Glomerulonephritis, Membranous / drug therapy
-
Glomerulonephritis, Membranous / therapy
-
Glomerulosclerosis, Focal Segmental / drug therapy
-
Glomerulosclerosis, Focal Segmental / therapy
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
-
Hypertension / drug therapy
-
Hypertension / prevention & control
-
Hyperuricemia / therapy
-
Kidney Diseases / diet therapy
-
Kidney Diseases / prevention & control*
-
Kidney Diseases / therapy
-
Kidney Failure, Chronic / prevention & control
-
Phosphates / metabolism
-
Pregnancy
-
Pregnancy Complications / therapy
-
Proteinuria / drug therapy
-
Renal Artery Obstruction / therapy
-
Smoking Cessation
-
Tonsillectomy
Substances
-
Analgesics
-
Angiotensin-Converting Enzyme Inhibitors
-
Antihypertensive Agents
-
Calcium Channel Blockers
-
Fish Oils
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Phosphates
-
Angiotensin II
-
Cyclosporine